Financial Advantage’s Exelon EXC Stock Holding History

Financial Advantage’s Portfolio EXC Stock Details EXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-271	Closed	-$10K	–	65
2022 Q3	$10K	Hold	271	–	–	0.01%	107
2022 Q2	$12K	Hold	271	–	–	0.01%	105
2022 Q1	$12K	Sell	271 -109	-29%	-$4.62K	0.01%	114
2021 Q4	$15K	Hold	380	–	–	0.01%	111
2021 Q3	$13K	Sell	380 -87	-19%	-$2.97K	0.01%	97
2021 Q2	$14K	Hold	467	–	–	0.01%	95
2021 Q1	$14K	Hold	467	–	–	0.01%	103
2020 Q4	$14K	Sell	467 -73	-14%	-$2.15K	0.01%	95
2020 Q3	$13K	Hold	540	–	–	0.01%	89
2020 Q2	$13K	Hold	540	–	–	0.01%	107
2020 Q1	$14K	Hold	540	–	–	0.01%	83
2019 Q4	$17K	Hold	540	–	–	0.01%	83
2019 Q3	$18K	Sell	540 -17	-3%	-$571	0.01%	120
2019 Q2	$19K	Hold	557	–	–	0.01%	77
2019 Q1	$19K	Hold	557	–	–	0.01%	80
2018 Q4	$17K	Buy	+557	New	+$17.8K	0.01%	75
2014 Q1	–	Sell	-365	Closed	-$7K	–	152
2013 Q4	$7K	Sell	365 -396	-52%	-$7.97K	0.01%	169
2013 Q3	$16K	Sell	761 -131	-15%	-$2.87K	0.01%	107
2013 Q2	$20K	Buy	+892	New	+$21.6K	0.02%	103

Other funds holding EXC

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Financial Advantage's EXC Position: Q4 2022 in Review

Financial Advantage sold out of Exelon (EXC) in Q4 2022, closing a stake of 271 shares — an estimated $10K sold.

Financial Advantage first reported a position in EXC in Q2 2013 and held it in 19 quarters. The position peaked at $20K in Q2 2013. 1,005 funds tracked by Wall St. Rank hold EXC as of Q4 2022.

Financial Advantage reported no remaining Exelon position as of Q4 2022 after selling out during the quarter.
Financial Advantage sold 271 Exelon shares in Q4 2022, an estimated $10K.
Financial Advantage first reported a position in Exelon in Q2 2013 and held it in 19 quarters.
Financial Advantage's Exelon position peaked at $20K in Q2 2013.
1,005 funds tracked by Wall St. Rank held Exelon as of Q4 2022.

Based on Financial Advantage's 13F filing for Q4 2022, filed 26 Jan 2023.